If a patient has a cephalosporin allergy and needs perioperative prophylaxis for orthopedic surgery, which options may be used?

If a patient has a cephalosporin allergy and needs perioperative prophylaxis for orthopedic surgery, which options may be used?

• A. Cefotaxime
• B. Piperacillin-Tazobactam
• C. Aztreonam
• D. Gentamicin and/or Vancomycin

Answer: (D)

When a patient has a cephalosporin allergy, you must avoid beta-lactam antibiotics and choose agents that provide broad coverage for the organisms most likely to cause implant infections. Orthopedic perioperative prophylaxis aims to protect against Staphylococcus species (including MRSA) and Gram-negative bacteria. Vancomycin is highly effective against Gram-positive cocci, including MRSA, making it a cornerstone for patients with beta-lactam allergies who are at risk for prosthetic joint infections. Gentamicin adds coverage against Gram-negative organisms, which is helpful in surgeries where Gram-negative pathogens are a concern. Using vancomycin alone or in combination with gentamicin offers broad, non–beta-lactam coverage appropriate for prophylaxis without risking a reaction to cephalosporins. In contrast, a cephalosporin or other beta-lactams would be avoided due to the allergy. Aztreonam, while safe for penicillin allergy, provides poor coverage of Gram-positive organisms, so it wouldn’t be adequate as sole prophylaxis for orthopedic implants. Piperacillin-tazobactam is a beta-lactam with potential cross-reactivity concerns in cephalosporin-allergic patients, and cefotaxime is a cephalosporin as well. The key point is that non–beta-lactam options like vancomycin (with or without an agent like gentamicin) are preferred to cover the typical pathogens without triggering an allergic reaction.

When a patient has a cephalosporin allergy, you must avoid beta-lactam antibiotics and choose agents that provide broad coverage for the organisms most likely to cause implant infections. Orthopedic perioperative prophylaxis aims to protect against Staphylococcus species (including MRSA) and Gram-negative bacteria. Vancomycin is highly effective against Gram-positive cocci, including MRSA, making it a cornerstone for patients with beta-lactam allergies who are at risk for prosthetic joint infections. Gentamicin adds coverage against Gram-negative organisms, which is helpful in surgeries where Gram-negative pathogens are a concern. Using vancomycin alone or in combination with gentamicin offers broad, non–beta-lactam coverage appropriate for prophylaxis without risking a reaction to cephalosporins.

In contrast, a cephalosporin or other beta-lactams would be avoided due to the allergy. Aztreonam, while safe for penicillin allergy, provides poor coverage of Gram-positive organisms, so it wouldn’t be adequate as sole prophylaxis for orthopedic implants. Piperacillin-tazobactam is a beta-lactam with potential cross-reactivity concerns in cephalosporin-allergic patients, and cefotaxime is a cephalosporin as well. The key point is that non–beta-lactam options like vancomycin (with or without an agent like gentamicin) are preferred to cover the typical pathogens without triggering an allergic reaction.